Inhibition of lipopolysaccharide stimulated interleukin-1β production after subarachnoid hemorrhage

Neurological Research

Volumn 29, Issue 1, 2007, Pages 47-52

  Kinoshita, Kosaku ^a   Yamaguchi, Junko ^a   Sakurai, Atsushi ^a   Ebihara, Takayuki ^a   Furukawa, Makoto ^a   Tanjoh, Katsuhisa ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute stress; Catecholamines; Cytokines; Inflammation; Lipopolysaccharide; Subarachnoid hemorrhage

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE STRESS; ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BLOOD SAMPLING; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOPAMINE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MALE; MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; SUBARACHNOID HEMORRHAGE; SUPERNATANT;

ADULT; BIOLOGICAL MARKERS; CATECHOLAMINES; CELLS, CULTURED; DOPAMINE; DOWN-REGULATION; ENCEPHALITIS; EPINEPHRINE; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; SUBARACHNOID HEMORRHAGE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33846643077     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313206X152500     Document Type: Article

References (28)

1. Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001; 32: 1989-1993
2. Gruber A, Reinprecht A, Illievich UM, et al. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 1999; 27: 505-514
3. Le Roux PD, Elliott JP, Downey L, et al. Improved outcome after rupture of anterior circulation aneurysms: A retrospective 10-year review of 224 good-grade patients. J Neurosurg 1995; 83: 394-402
4. Le Roux PD, Elliott JP, Newell DW, et al. Predicting outcome in poor-grade patients with subarachnoid hemorrhage: A review of 159 aggressively managed cases. J Neurosurg 1996; 85: 39-49
5. Solenski NJ, Haley EC, Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: A report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 1995; 23: 1007-1017
6. Elrifai AM, Bailes JE, Shih SR, et al. Characterization of the cardiac effects of acute subarachnoid hemorrhage in dogs. Stroke 1996; 27: 737-742
7. Severn A, Rapson NT, Hunter CA, et al. Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol 1992; 148: 3441-3445
8. van der Poll T, Jansen J, Endert E, et al. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 1994; 62: 2046-2050
9. Ichijo T, Katafuchi T, Hori T. Central interleukin-1 beta enhances splenic sympathetic nerve activity in rats. Brain Res Bull 1994; 34: 547-553
10. Madden KS, Sanders VM, Felten DL. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 1995; 35: 417-448
11. Terao A, Oikawa M, Saito M. Tissue-specific increase in norepinephrine turnover by central interleukin-1, but not by interleukin-6, in rats. Am J Physiol 1994; 266: R400-R404
12. Chelmicka-Schorr E, Kwasniewski MN, Czlonkowska A. Sympathetic nervous system and macrophage function. Ann NY Acad Sci 1992; 650: 40-45
13. Meisel C, Vogt K, Platzer C, et al. Differential regulation of monocytic tumor necrosis factor-alpha and interleukin-10 expression. Eur J Immunol 1996; 26: 1580-1586
14. Platzer C, Meisel C, Vogt K, et al. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol 1995; 7: 517-523
15. van der Poll T, Coyle SM, Barbosa K, et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97: 713-719
16. West MA, Baker J, Bellingham J, et al. Discordant reprogramming of LPS-stimulated cytokine gene transcription and secretion by macrophages after LPS pretreatment. J Surg Res 1996; 63: 209-214
17. West MA, LeMieur T, Clair L, et al. Protein kinase C regulates macrophage tumor necrosis factor secretion: Direct protein kinase C activation restores tumor necrosis factor production in endotoxin tolerance. Surgery 1997; 122: 204-211
18. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 1994; 653: 131-138
19. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480-484
20. Woiciechowsky C, Asadullah K, Nestler D, et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998; 4: 808-813
21. Kassell NF, Boarini DJ, Adams HP Jr, et al. Overall management of ruptured aneurysms: Comparison of early and late operation. Neurosurgery 1981; 9: 120-128
22. Goldberg LI. Dopamine-clinical uses of an endogenous catecholamine. N Engl J Med 1974; 291: 707-710
23. D'Orio V, el Allaf D, Juchmes J, et al. The use of low doses of dopamine in intensive care medicine. Arch Int Physiol Biochim 1984; 92: S11-S20
24. Riese U, Brenner S, Docke WD, et al. Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T-cells. Mol Cell Biochem 2000; 212: 45-50
25. Munoz C, Carlet J, Fitting C, et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88: 1747-1754
26. Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation- rationale for a new therapeutic strategy in sepsis. Intensive Care Med 1996; 22: S474-S481
27. Zedler S, Bone RC, Baue AE, et al. T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med 1999; 27: 66-72
28. Flohe S, Lendemans S, Schade FU, et al. Influence of surgical intervention in the immune response of severely injured patients. Intensive Care Med 2004; 30: 96-102